TYCHE INDUSTRIES
|
The Current P/E Ratio of TYCHE INDUSTRIES is 24.13.
| Share Price | ₹104.4 | Sep 29,2026 |
| Market Cap | ₹107.5 Cr | |
| Earnings-TTM | ₹4.5 Cr | TTM-Standalone Results |
| Price/Earnings | 24.13x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of TYCHE INDUSTRIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹107.5 Cr] as on Sep 29,2026
(/) Earnings [ ₹4.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 24.13x ]
Thus, for TYCHE INDUSTRIES , the investors are currently willing to pay 24.13 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TYCHE INDUSTRIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of TYCHE INDUSTRIES over the last five years.
Historical PE (Price/Earnings) ratio chart of TYCHE INDUSTRIES
PE Ratio Performance Analysis for TYCHE INDUSTRIES
- TYCHE INDUSTRIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 11.94x.
- TYCHE INDUSTRIES 's operated at median p/e ratio of 10.99x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TYCHE INDUSTRIES 's p/e ratio peaked in Mar2022 at 15.17x.
- TYCHE INDUSTRIES 's p/e ratio hit its five-year low in Mar2021 of 8.74x.
How does TYCHE INDUSTRIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| TYCHE INDUSTRIES | 4.46 | 24.13 | 107.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 36.66 | 446,276.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 85.99 | 251,531.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 86.71 | 186,957.0 |
| CIPLA LTD | 3,364.84 | 33.20 | 111,729.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 32.92 | 104,335.0 |
| MANKIND PHARMA LTD | 2,055.11 | 51.15 | 105,120.0 |
| LUPIN LTD | 5,551.01 | 16.97 | 94,201.7 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 26.54 | 119,222.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.39 | 97,986.9 |
| LAURUS LABS LTD | 1,090.76 | 98.36 | 107,284.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TYCHE INDUSTRIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 16.97x |
| Max industry PE | 98.36x |
| Median industry PE | 33.20x |
| Average industry PE | 47.19x |
You may also like the below Video Courses